Your browser doesn't support javascript.
loading
Refining the definition of HER2-low class in invasive breast cancer.
Atallah, Nehal M; Toss, Michael S; Green, Andrew R; Mongan, Nigel P; Ball, Graham; Rakha, Emad A.
Afiliação
  • Atallah NM; Department of Histopathology, School of Medicine, the University of Nottingham and Nottingham University, Hospitals NHS Trust, Nottingham, UK.
  • Toss MS; Department of Pathology, Faculty of Medicine, Menoufia University, Menoufia, Egypt.
  • Green AR; Division of Cancer and Stem Cells, Biodiscovery Institute, School of Medicine, University of Nottingham, Nottingham, UK.
  • Mongan NP; Division of Cancer and Stem Cells, Biodiscovery Institute, School of Medicine, University of Nottingham, Nottingham, UK.
  • Ball G; Histopathology Department, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
  • Rakha EA; Division of Cancer and Stem Cells, Biodiscovery Institute, School of Medicine, University of Nottingham, Nottingham, UK.
Histopathology ; 81(6): 770-785, 2022 Dec.
Article em En | MEDLINE | ID: mdl-36030496
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Imunoconjugados Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Imunoconjugados Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article